HemaSphere (Jun 2022)

P1428: IMPLICATIONS OF THE RUXOLITINIB (JAK1/JAK2 INHIBITOR) ON GRAFT-VERSUS-LEUKAEMIA EFFECT MEDIATED BY THE NK CELL.

  • C. Durán,
  • C. Martín Cortázar,
  • C. Ferreras,
  • A. Navarro Zapata,
  • L. Clares Villa,
  • K. Al-akioui,
  • A. Escuredo,
  • A. Pernas,
  • V. Galán,
  • D. Bueno,
  • L. Sisinni,
  • A. Pérez Martínez

DOI
https://doi.org/10.1097/01.HS9.0000848568.92492.6e
Journal volume & issue
Vol. 6
pp. 1311 – 1312

Abstract

Read online

No abstracts available.